About $50 billion in settlement offers by drug makers and distributors have sparked a fight between state attorneys general and thousands of local governments over how much the pharmaceutical industry should pay for its role in creating the U.S.
Drug maker
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.